Evaluation and Modeling with the Therapeutic Effects Group

Members

EMET  presentation

The EMET team brings together doctors, pharmacists and research professors specializing in the evaluation and use of drug and non-drug therapies, around a single project built on two axes:

  • the evaluation of therapies in clinical trials or observational studies;
  • the construction of explanatory and predictive models, to better understand and therefore predict the effect of therapies, simulate their impacts at the individual and population level, and improve the innovation paradigm.

The EMET team is therefore part of two major dynamics in therapy: analysis of the level of evidence and precision medicine.
The fields of application are cardiovascular and metabolic diseases, primary care medicine, rare pediatric diseases (including genetic and autoimmune diseases), oncology and infectious diseases.
EMET members implement approaches using different mathematical models: direct comparison and network meta-analysis, pharmacokinetic/pharmacodynamic analysis, Bayesian networks and machine learning.

Education

The EMET team is specially involved in the teaching of pharmacology and therapeutics and the modeling of the treatment effect through the coordination of the Masters 2 Clinical Evaluation (EC) and Pharmacology modeling and clinical trials (PHAME), Interpretation of Therapeutic Trials (IET), Training of investigators in clinical drug trials (FIEC) and Training of clinical research assistants and clinical study technicians (FARCTEC). Teacher-researchers are also involved in the first (pharmacology), second (pharmacology / therapeutics, pharmacy) and third cycles (general medicine, pediatrics, internal medicine) in health training courses.

Society involvement

The members of the EMET team through their work and their interactions with the other components of the LBBE, National societies, governmental (HAS) or international (EMA) agencies, and the Hospices Civils de Lyon, are invested in current societal issues: rationalization of the use of health product resources, research ethics, gender equality, rationality of approaches in analyzing the diversity of human populations.

Publications

Display of 391 to 420 publications on 613 in total

Is legacy a myth or a reality? We should know, and we do not

F. Gueyffier, Michel Cucherat

Journal of Hypertension . 33 : 2207-9

Journal article

see the publication

High Risk versus Proportional Benefit: Modelling Equitable Strategies in Cardiovascular Prevention

I. Marchant, Jp. Boissel, Patrice Nony, F. Gueyffier

PLoS ONE . 10 ( 11 ) : e0140793

DOI: 10.1371/journal.pone.0140793

Journal article

see the publication

A Prediction Model of Drug Exposure in Cirrhotic Patients According to Child-Pugh Classification

J. Steelandt, E. Jean-Bart, Sylvain Goutelle, M. Tod

Clinical Pharmacokinetics . 54 : 1245-58

DOI: 10.1007/s40262-015-0288-9

Journal article

see the publication

Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age

W. Zhao, H. Hill, C. Le Guellec, T. Neal, S. Mahoney, S. Paulus...

Antimicrobial Agents and Chemotherapy . 58 ( 11 ) : 6572-80

DOI: 10.1128/AAC.03568-14

Journal article

see the publication

Solid oral forms availability in children: a cost saving investigation

A. Lajoinie, E. Henin, Behrouz Kassai, D. Terry

British Journal of Clinical Pharmacology . 78 ( 5 ) : 1080-9

DOI: 10.1111/bcp.12442

Journal article

see the publication

Practical interest of both skin prick test and specific IgE in the evaluation of tolerance acquisition in IgE mediated cow's milk allergy (CMA). A clinical retrospective study in a cohort of 184 children

F. Payot, J. Berthiller, Behrouz Kassai, A. S. Brunet, F. Villard-Truc, A. Lachaux

Allergologia et Immunopathologia . 42 : 395-401

Journal article

see the publication

Pharmacokinetic Drug-Drug Interaction of Calcium Channel Blockers With Cyclosporine in Hematopoietic Stem Cell Transplant Children

Elodie Bernard, Sylvain Goutelle, Yves Bertrand, Nathalie Bleyzac

Annals of Pharmacotherapy . 48 ( 12 ) : 1580-1584

DOI: 10.1177/1060028014550644

Journal article

see the publication

Determinants of Torsades de Pointes in Older Patients with Drug-Associated Long QT Syndrome: A Case-Control Study

Sylvain Goutelle, Elodie Sidolle, Michel Ducher, Jacques Caron, Quadiri Timour, Patrice Nony...

Drugs and Aging . 31 ( 8 ) : 601-609

DOI: 10.1007/s40266-014-0188-y

Journal article

see the publication

Response to Sarah Hilmer and Colleagues

Christelle Mouchoux, Rémi Faure, Virginie Dauphinot, Sylvain Goutelle, Pierre Krolak-Salmon

Journal of the American Geriatrics Society . 62 ( 4 ) : 792-793

DOI: 10.1111/jgs.12754

Journal article

see the publication

Exposure of Staphylococcus aureus to subinhibitory concentrations of β-lactam antibiotics induces heterogeneous vancomycin-intermediate Staphylococcus aureus

Mélanie Roch, Perrine Clair, Adriana Renzoni, Marie-Elisabeth Reverdy, Olivier Dauwalder, Michèle Bes...

Antimicrobial Agents and Chemotherapy . 58 ( 9 ) : 5306-5314

DOI: 10.1128/AAC.02574-14

Journal article

see the publication

Impact of Scedosporium apiospermum complex seroprevalence in patients with cystic fibrosis

Perrine Parize, Sandrine Nail-Billaud, Anne-Lise Bienvenu, Stéphanie Bourdy, Marie Le Pogam, Philippe Reix...

Journal of Cystic Fibrosis . 13 ( 6 ) : 667-673

DOI: 10.1016/j.jcf.2014.01.011

Journal article

see the publication

Consistency of safety profile of new oral anticoagulants in patients with renal failure

Jean-Christophe Lega, L. Bertoletti, C. Gremillet, C. Boissier, P. Mismetti, S. Laporte

Journal of Thrombosis and Haemostasis . 12 ( 2 ) : 337-43

DOI: 10.1111/jth.12486

Journal article

see the publication

Characteristics, prognosis, and outcomes of cutaneous ischemia and gangrene in systemic necrotizing vasculitides: a retrospective multicenter study

Jean-Christophe Lega, Raphaèle Seror, Thomas Fassier, Olivier Aumaître, Isabelle Quere, Jacques Pourrat...

Seminars in Arthritis and Rheumatism . 43 ( 5 ) : 681--688

DOI: 10.1016/j.semarthrit.2013.09.001

Journal article

see the publication

The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome

Jean-Christophe Lega, N. Fabien, Q. Reynaud, I. Durieu, S. Durupt, M. Dutertre...

Autoimmunity Reviews . 13 : 883-91

Journal article

see the publication

The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome

Jean-Christophe Lega, Nicole Fabien, Quitterie Reynaud, Isabelle Durieu, Stéphane Durupt, Marine Dutertre...

Autoimmunity Reviews . 13 ( 9 ) : 883-891

DOI: 10.1016/j.autrev.2014.03.004

Journal article

see the publication

Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis

Q. Reynaud, Jean-Christophe Lega, P. Mismetti, C. Chapelle, D. Wahl, P. Cathebras...

Autoimmunity Reviews . 13 : 595-608

Journal article

see the publication

Consistency of Safety and Efficacy of New Oral Anticoagulants across Subgroups of Patients with Atrial Fibrillation

Jean-Christophe Lega, L. Bertoletti, C. Gremillet, C. Chapelle, P. Mismetti, M. Cucherat...

PLoS ONE . 9 ( 3 ) : e91398

DOI: 10.1371/journal.pone.0091398

Journal article

see the publication

Mutations in CECR1 associated with a neutrophil signature in peripheral blood

Alexandre Belot, Evangeline Wassmer, Marinka Twilt, Jean-Christophe Lega, Leo Ah Zeef, Anthony Oojageer...

Pediatric Rheumatology . 12 : 44

DOI: 10.1186/1546-0096-12-44

Journal article

see the publication

Comparison of an effect-model-law-based method versus traditional clinical practice guidelines for optimal treatment decision-making: application to statin treatment in the French population

R. Kahoul, François Gueyffier, E. Amsallem, M. Haugh, I. Marchant, F. H. Boissel...

Journal of the Royal Society Interface . 11 ( 100 ) : 20140867

DOI: 10.1098/rsif.2014.0867

Journal article

see the publication

The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial

Laurence Lion-François, François Gueyffier, Catherine Mercier, Daniel Gérard, Vania Herbillon, Isabelle Kemlin...

Orphanet Journal of Rare Diseases . 9 : 142

DOI: 10.1186/s13023-014-0142-4

Journal article

see the publication

Effects of pharmacological treatments on micro- and macrovascular complications of type 2 diabetes: What is the level of evidence?

R. Boussageon, François Gueyffier, Catherine Cornu

Diabetes & Metabolism . 40 : 169-75

DOI: 10.1016/j.diabet.2013.12.010

Journal article

see the publication

Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease

S. Gaillard, S. Dupuis-Girod, F. Boutitie, S. Riviere, S. Moriniere, P. Y. Hatron...

Journal of Thrombosis and Haemostasis . 12 : 1494-502

DOI: 10.1111/jth.12654

Journal article

see the publication

Improving risk prediction performance for a better guidelines application

I. Marchant, T. Bejan-Angoulvant, Hh. Le, François Gueyffier

Journal of Hypertension . 32 : 1192-1193

Journal article

see the publication

The Case for Using Higher Doses of First Line Anti-Tuberculosis Drugs to Optimize Efficacy

Sylvain Goutelle, Laurent Bourguignon, P. Maire, R. W. Jelliffe, M. Neely

Current Pharmaceutical Design . 20 : 6191-6206

Journal article

see the publication

Impact of the reduction of calcineurin inhibitors on renal function in heart transplant patients: a systematic review and meta-analysis

Catherine Cornu, C. Dufays, Ségolène Gaillard, François Gueyffier, M. Redonnet, Laurent Sebbag...

British Journal of Clinical Pharmacology . 78 ( 1 ) : 24-32

DOI: 10.1111/bcp.12289

Journal article

see the publication

Cardiovascular Events and Bleeding Risk Associated With Intravitreal Antivascular Endothelial Growth Factor Monoclonal Antibodies: Systematic Review and Meta-analysis

M. Thulliez, D. Angoulvant, M. L. Le Lez, Annie-Pierre Jonville-Bera, P. J. Pisella, François Gueyffier...

JAMA Ophthalmology . 132 ( 11 ) : 1317-26

DOI: 10.1001/jamaophthalmol.2014.2333

Journal article

see the publication

Guidelines for Managing High Blood Pressure

Dk. Cundiff, François Gueyffier, Jm. Wright

Journal of the American Medical Association . 312 ( 3 ) : 293-294

DOI: 10.1001/jama.2014.6590

Journal article

see the publication

Multivariate meta-analysis using individual participant data

R. D. Riley, M. J. Price, D. Jackson, M. Wardle, François Gueyffier, J. Wang...

Research Synthesis Methods . 6 ( 2 ) : 157-174

DOI: 10.1002/jrsm.1129

Journal article

see the publication

Can we identify response markers to antihypertensive drugs? First results from the Ideal Trial.

Gueyffier F., Subtil F., Bejan-Angoulvant T., Yves Zerbib, Baguet Jp, Boivin Jm...

Journal of Human Hypertension . : doi: 10.1038/jhh.2014.29

Journal article

see the publication

Determinants of torsades de pointes in older patients with drug-associated long QT syndrome: a case-control study

Sylvain Goutelle, E. Sidolle, M. Ducher, J. Caron, Q. Timour, Patrice Nony...

Drugs & aging . 31 : 601-9

Journal article

see the publication

You also, comment on this article

Choose an avatar
(Will not be posted on the site)
(Will not be posted on the site)